Clinical Trial Update: Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter [Phase 2]

View source ↗

Summary

Phase 2 trial updating the pharmacokinetics and safety of MK-4448 in participants with atrial fibrillation or atrial flutter has been completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• MK-4448

Snippet

Sponsor: Portola Pharmaceuticals | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 2 | Status: COMPLETED | Results posted: 2017-09-18